BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24311638)

  • 1. Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.
    Barney CL; Brown AP; Grosshans DR; McAleer MF; de Groot JF; Puduvalli V; Tucker SL; Crawford CN; Gilbert MR; Brown PD; Mahajan A
    Neuro Oncol; 2014 Jan; 16(2):303-9. PubMed ID: 24311638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors.
    Uemura S; Demizu Y; Hasegawa D; Fujikawa T; Inoue S; Nishimura A; Tojyo R; Nakamura S; Kozaki A; Saito A; Kishimoto K; Ishida T; Mori T; Koyama J; Kawamura A; Akasaka Y; Yoshida M; Fukumitsu N; Soejima T; Kosaka Y
    Cancer Med; 2022 Mar; 11(6):1502-1510. PubMed ID: 35137555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.
    Gunther JR; Rahman AR; Dong W; Yehia ZA; Kebriaei P; Rondon G; Pinnix CC; Milgrom SA; Allen PK; Dabaja BS; Smith GL
    Pract Radiat Oncol; 2017; 7(6):e401-e408. PubMed ID: 28666906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component.
    O'Leary B; Mandeville HC; Fersht N; Solda F; Mycroft J; Zacharoulis S; Vaidya S; Saran F
    J Neurooncol; 2016 Apr; 127(2):295-302. PubMed ID: 26842817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.
    Brown AP; Barney CL; Grosshans DR; McAleer MF; de Groot JF; Puduvalli VK; Tucker SL; Crawford CN; Khan M; Khatua S; Gilbert MR; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):277-84. PubMed ID: 23433794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
    Liu IC; Holtzman AL; Rotondo RL; Indelicato DJ; Gururangan S; Cavaliere R; Carter B; Morris CG; Tavanaiepour D; Rutenberg MS
    J Neurooncol; 2021 Jul; 153(3):467-476. PubMed ID: 34105033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
    Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric de-escalation and improved acute toxicity with proton craniospinal irradiation using a vertebral body-sparing technique.
    Chou B; Hopper A; Elster J; Crawford JR; McConnell K; Chang A; Mundt AJ; MacEwan I
    Pediatr Blood Cancer; 2022 May; 69(5):e29489. PubMed ID: 34866330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
    Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center.
    Chang EL; Allen P; Wu C; Ater J; Kuttesch J; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1008-16. PubMed ID: 11958896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encouraging early outcomes with image guided pencil beam proton therapy for cranio-spinal irradiation: first report from India.
    Gaikwad U; Noufal MP; Sylvia J; Reddy AK; Panda PK; Chilukuri S; Sharma D; Jalali R
    Radiat Oncol; 2022 Jun; 17(1):115. PubMed ID: 35773667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phantosmia during proton radiation and differences in frequency of phantosmia rates based on proton craniospinal irradiation technique for pediatric brain tumor patients.
    Ioakeim-Ioannidou M; Daartz J; Erfani P; Urell T; Lalonde A; Berv J; Leahy S; Fullerton B; Bolton R; Yock T; Tarbell N; Yeap B; MacDonald SM
    Pediatr Blood Cancer; 2024 May; 71(5):e30927. PubMed ID: 38421306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
    Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
    J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
    Luo LY; Kramer K; Cheung NV; Kushner BH; Modak S; Basu EM; Roberts SS; Wolden SL
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28364. PubMed ID: 32608559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors.
    Song S; Park HJ; Yoon JH; Kim DW; Park J; Shin D; Shin SH; Kang HJ; Kim SK; Phi JH; Kim JY
    Acta Oncol; 2014 Sep; 53(9):1158-64. PubMed ID: 24913151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults.
    Hashimoto T; Shimizu S; Takao S; Terasaka S; Iguchi A; Kobayashi H; Mori T; Yoshimura T; Matsuo Y; Tamura M; Matsuura T; Ito YM; Onimaru R; Shirato H
    J Radiat Res; 2019 Jul; 60(4):527-537. PubMed ID: 31111946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
    Suzuki S; Kato T; Murakami M
    J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
    Napieralska A; BrÄ…clik I; Radwan M; Mandera M; Blamek S
    Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.